(20278119), M. i. D., (16932579), M. F. M., (10223507), M. N. E., (9376835), H. F., (18131404), S. A. S., (5961536), S. M., . . . (20278128), M. B. (2020). Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)(20278119), Mohammed ibn-Mas’ud Danjuma, et al. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants (DOACS) for the Reduction of Recurrent Venous Thromboembolism in Cancer Patients. 2020.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)(20278119), Mohammed ibn-Mas’ud Danjuma, et al. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants (DOACS) for the Reduction of Recurrent Venous Thromboembolism in Cancer Patients. 2020.